mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |